Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-29

Clinical Trial Update: Effects of Carnosine In Patients With Peripheral Arterial Disease Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the effects of carnosine in patients with peripheral arterial disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carnosine (carnosine)

Snippet

Sponsor: Shahid Baba | Conditions: Peripheral Arterial Disease | Phase 1, Phase 2 | Status: RECRUITING